title: Association of essential thrombocythemia and chronic lymphocytic leukemia: absence of the V617F JAK2 mutation in the lymphoid compartment.
authors.forename: Laurent
authors.initials: L
authors.lastname: Henry
authors.forename: Serge
authors.initials: S
authors.lastname: Carillo
authors.forename: Eric
authors.initials: E
authors.lastname: Jourdan
authors.forename: Anne
authors.initials: A
authors.lastname: Arnaud
authors.forename: Sophie
authors.initials: S
authors.lastname: Brun
authors.forename: Thierry
authors.initials: T
authors.lastname: Lavabre-Bertrand
mesh_terms: D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D053614:Janus Kinase 2 / Q000235:genetics*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D008232:Lymphoproliferative Disorders / Q000235:genetics*; D008875:Middle Aged; D017354:Point Mutation; D013920:Thrombocythemia, Essential / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*
chemical_list: C507924:JAK2 protein, human; D053614:Janus Kinase 2; D006918:Hydroxyurea